• Underlying revenue of $1.7 billion, up 13.3% led by strong Commodities performance
• Underlying EBIT of $287.2 million, up 14.7% with margin strengthening to 17.3%
• Interim dividend of 19.4 cps, up 2.6% vs pcp

ALS delivered a strong first half result for FY26, with organic revenue growth recorded across all business streams, resilient margins, and both underlying earnings and profit considerably up. Underlying revenue increased 13.3% to $1.7 billion, led by a 14.3% (12.0% in constant currency) rise in Commodities. Underlying EBIT grew 14.7% to $287.2 million, with the overall margin strengthening by 20 basis points to 17.3%. Statutory NPAT increased 11.8% to $141.7 million. The Commodities division saw resilient margins above 31%, reflecting the benefits of operating leverage and disciplined cost management. Life Sciences performance was slightly below expectations but still delivered a strong result, led by the Food business. The company's disciplined capital deployment and balance sheet strength position it well to deliver another year of growth. ALS remains focused on delivering top-tier services to customers consistently, safely and reliably, and is on track to deliver 6-8% organic revenue growth and steady margin improvement in FY26.

ALS is targeting 6-8% organic revenue growth and steady margin improvement in FY26. In Commodities, the company anticipates 12-14% organic revenue growth, with incremental margin expansion of 100-125 bps in H2 FY26. In Life Sciences, the company expects 4-6% organic revenue growth and continued margin improvement of 20-40 bps within legacy operations.

ALS remains well on track to execute on its strategy and meet the FY27 financial targets including growing revenue to $3.3 billion and growing underlying EBIT to $600 million, with a Group EBIT margin floor of 19%.